During the past decade, Institut de la Macula i la retina conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 4 clinical trials were completed, i.e. on average, 26.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut de la Macula i la retina" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Institut de la Macula y la Retina" with 5 trials sponsored, "IVERIC bio, Inc." with 2 trials sponsored, "Barcelona Macula Foundation" with 1 trials sponsored and "Kodiak Sciences Inc" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut de la Macula i la retina" #1 collaborator was "Igen BioLab SLU" with 2 trials as a collaborator and "Centro Medico Teknon" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Institut de la Macula i la retina" are "Geographic Atrophy" (8 trials), "Retinitis Pigmentosa" (2 trials), "Stargardt Disease 1" (2 trials), "Wet Macular Degeneration" (2 trials) and "AMD" (1 trials). Many other conditions were trialed in "Institut de la Macula i la retina" in a lesser frequency.

Most popular intervention types in "Institut de la Macula i la retina" are "Drug" (11 trials), "Other" (6 trials), "Procedure" (3 trials), "Dietary Supplement" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (4 trials), "Aflibercept" (3 trials), "Faricimab" (3 trials), "Sham" (3 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Institut de la Macula i la retina" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Institut de la Macula i la retina". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Institut de la Macula i la retina, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Institut de la Macula i la retina, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".